Quick answer
Semaglutide is dosed by gradual titration: you start at a low dose and increase step by step over several months, holding each dose for about four weeks before going up, until you reach the maintenance dose. This is true for both Wegovy (for weight management) and Ozempic (for diabetes), though their schedules and maximum doses differ. The slow ramp exists to limit gastrointestinal side effects, not to delay results. A prescriber individualizes the schedule, sometimes holding longer at a dose if side effects are strong. These are prescription medications requiring physician supervision, and individual results vary.
Why Is Semaglutide Started at a Low Dose?
Semaglutide is started low and increased gradually because its gastrointestinal side effects, especially nausea, are worst when the body first encounters the drug or when the dose jumps. Beginning at a low dose like 0.25 mg weekly gives your system time to adjust before stepping up. The starting dose is generally too low to produce full therapeutic effect; it is there to build tolerance, which is why no one stays on it.
This is the single most important thing to understand about GLP-1 dosing: the ramp is for tolerability, not impatience. Pushing the dose faster than the schedule allows tends to cause more side effects without speeding meaningful results. A prescriber controls the pace, and the right pace is the one you can tolerate while progressing.
What Is the Wegovy Dosage Schedule for Weight Loss?
For weight management, Wegovy follows a step-up schedule that increases roughly every four weeks. The typical sequence is 0.25 mg weekly for the first month, then 0.5 mg, then 1.0 mg, then 1.7 mg, and finally the 2.4 mg maintenance dose, reaching maintenance over about four to five months. Each step is usually held for about four weeks before the next increase, and the final maintenance dose is what is intended for ongoing use.
Not everyone reaches 2.4 mg. If side effects are strong at a given step, a prescriber may hold you there longer or keep you at a lower maintenance dose that you tolerate while still benefiting. The schedule is a default starting framework that gets individualized, which is why this is supervised care rather than a fixed prescription you self-manage. For the bigger picture on results, see our guide on semaglutide for weight loss.
How Is the Ozempic Dosage Schedule Different?
Ozempic, the diabetes product, also titrates up gradually but to a different maximum. It typically starts at 0.25 mg weekly for the first four weeks (a starting dose, not a treatment dose), then increases to 0.5 mg, and can step up to 1.0 mg and then 2.0 mg weekly depending on blood-sugar response and tolerance. The increments are held for about four weeks each, like Wegovy, but the top dose is lower than Wegovy's 2.4 mg.
The reason the schedules differ is that the products were studied and approved for different uses with different target doses. This is also why you should never assume a dose from one product maps directly to the other; switching between them is a prescriber's decision. For how the two brands differ overall, see our guide on Ozempic vs Wegovy.
What If You Miss a Dose or Have Strong Side Effects?
If you miss a dose, the right action depends on how long it has been, and there are specific rules in the product labeling, so this is a question for your prescriber or pharmacist rather than a guess. If side effects are strong at a dose, the usual response is not to stop but to hold at that dose longer before increasing, adjust food choices and portions, and stay hydrated, all under your clinician's guidance. Doses are not meant to be doubled up to catch up.
The schedule is a guide, not a contract, and a good prescriber adapts it to you. Reporting strong or persistent side effects promptly lets your clinician adjust the plan before you are tempted to quit. Ascend's medical weight loss program supervises titration and adjusts the schedule based on how you respond.
Care at Ascend: Learn more about Weight Loss at Ascend Mind and Body, or book an appointment.
Frequently asked questions
How long does it take to reach the full semaglutide dose?
For Wegovy, reaching the 2.4 mg maintenance dose typically takes about four to five months of gradual titration, holding each step for around four weeks. Ozempic reaches its maintenance dose over a similar gradual schedule to a lower maximum. Some people take longer if doses are held to manage side effects, which is normal and appropriate.
Can I increase my semaglutide dose faster to lose weight quicker?
No, you should not, and a responsible prescriber will not. Faster titration tends to cause more side effects without meaningfully speeding results, and skipping the ramp can make treatment intolerable. The schedule is built around tolerability. Dose changes are a clinical decision your prescriber makes based on how you respond.
Do I need a prescription to get semaglutide dosing managed in Florida?
Yes. Semaglutide is a prescription medication, and titration must be supervised by a licensed clinician in Florida and everywhere in the United States. Self-managing dose changes without supervision is unsafe and is one reason these drugs are prescription-only. A prescriber sets and adjusts your schedule.
Can my semaglutide dose be adjusted by telehealth in Florida?
Often, yes. Florida law allows licensed clinicians to provide follow-up care, including dose adjustments and lab orders, by telehealth when it meets the standard of care. This makes ongoing titration management convenient while keeping it supervised. Ascend offers supervised follow-up as part of its weight-loss program.
Medically reviewed by
Dr. Jason Saylor, DO
This article is for general educational purposes only and is not medical advice. It does not create a provider-patient relationship. Talk with a qualified Florida-licensed clinician about your individual situation.
Sources
- U.S. Food and Drug Administration. Wegovy (semaglutide) injection prescribing information. accessdata.fda.gov.
- U.S. Food and Drug Administration. Ozempic (semaglutide) injection prescribing information. accessdata.fda.gov.
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Prescription Medications to Treat Overweight and Obesity. niddk.nih.gov.